Skip to content

Study of autoinflammatory diseases in India

Understanding autoinflammatory disorders through clinical, genomic and functional approaches

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035958
Enrollment
150
Registered
2021-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Dhanya Lakshmi N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals who fulfill the clinical diagnostic criteria for a specific autoinflammatory disease 2. Individuals with clinical features like recurrent fever, oral ulcers, non- infectious osteolytic lesions, synovitis, arthritis or rash and elevated inflammatory markers like C reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR) or family history suggestive of a monogenic autoinflammatory disease. 3. Individuals with undefined periodic fevers characterised by recurrent attacks of fever with a temperature of at least 38.5°C (axillary) for a period of at least 6 months, associated with increased acute phase reactants during the episodes and normal clinical and laboratory features in between attacks and not fulfilling the inclusion criteria for PFAPA, MKD, FMF, TRAPS, CAPS where other causes of recurrent fever are excluded

Exclusion criteria

Exclusion criteria: 1. Individuals with malignancy 2. Individuals with infection, sepsis or any other medical condition, which would warrant exclusion in the opinion of a clinical immunologist/ clinical geneticist

Design outcomes

Primary

MeasureTime frame
- Systematic documentation of phenotypes of autoinflammatory diseases - Genomic landscape of autoinflammatory diseases in India will be unraveled - Novel gene disease associations may be discovered - Improved genetic diagnosis, clinical care and genetic counseling for familiesTimepoint: -At the end of each year -Recruitment will be completed by the end of year 4

Secondary

MeasureTime frame
- Development of a cost effective NGS based panel testing for autoinflammatory diseases in India. - Potential impact on therapeutic strategies for treatment of autoinflammatory diseases. Timepoint: 5 years

Countries

India

Contacts

Public ContactDr Dhanya Lakshmi N

Kasturba Medical College

dhanya.lakshmi@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026